Cardiac adenosine release is thought to depend on the oxygen supply/demand ratio, and this effect may be mediated by changes in high energy phosphate concentrations. Previous studies supporting this hypothesis have been done primarily in isolated hearts. We tested this hypothesis in intact dog hearts. Anesthetized, open-chest dogs were placed in a 4.7-T magnet where 31P nuclear magnetic resonance spectra were acquired via a surface coil over the heart at 2-minute intervals (60 scans, 2-second interpulse delay). Coronary sinus flow was shunted through a flow probe and returned via a jugular vein. After a control period, intracoronary norepinephrine was infused (12 ,ug/min) for 16 minutes and plasma samples were taken every 5 minutes. The phosphocreatine/ATP peak area ratio was used as an index of high energy phosphate changes. During norepinephrine infusion, arterial pressure, heart rate, coronary sinus flow, oxygen consumption, and adenosine release all increased significantly. Adenosine release peaked at 5 minutes but remained elevated after 15 minutes. There was a transient fall in the phosphocreatine/ATP ratio (9.2±3.1%, p<O.0S) during the first 7 minutes, but the ratio returned to control levels by 9 minutes. The oxygen supply/consumption ratio increased after 5 minutes of norepinephrine infusion and then returned to control levels. We Most interventions that increase cardiac adenosine formation are accompanied by a decrease in the oxygen supply/demand ratio.6 The link between a decrease in this ratio and increased adenosine formation could be increased AMP concentration7 and/or allosteric activation of cytosolic 5'-nucleotidase.6 The allosteric activation of 5'-nucleotidase might occur via increased cytosolic ADP or decreased ATP concentrations.8 Either mechanism therefore requires a net breakdown of ATP to ADP and AMP. Studies of isolated hearts support this hypothesis. Both catecholamine infusion and pacing decrease the adenine nucleotide phosphorylation po-
A
denosine is an important extracellular messenger in the heart. It causes vasodilation, inhibits norepinephrine (NE) release from sympathetic nerves, and has negative chronotropic and dromotropic effects and anti-f3-adrenergic effects.1 The regulation of cardiac adenosine formation remains incompletely understood. Recent evidence from isolated hearts suggests that basal adenosine release rates can be accounted for by the activity of S-adenosyl homocysteine hydrolase but that elevated adenosine formation during periods of oxygen supply/demand imbalance results from the action of cytosolic 5'-nucleotidase on AMP.2 Intracellularly formed adenosine is then transported into the extracellular fluid by a membrane nucleoside carrier. In isolated hearts endothelial cells are responsible for roughly 15% of basal adenosine release,3 but they are responsible for a much lower percentage during increased adenosine release provoked by catecholamine infusion or hypoxia. 4, 5 Most interventions that increase cardiac adenosine formation are accompanied by a decrease in the oxygen supply/demand ratio. 6 The link between a decrease in this ratio and increased adenosine formation could be increased AMP concentration7 and/or allosteric activation of cytosolic 5'-nucleotidase. 6 The allosteric activation of 5'-nucleotidase might occur via increased cytosolic ADP or decreased ATP concentrations. 8 Either mechanism therefore requires a net breakdown of ATP to ADP and AMP. Studies of isolated hearts support this hypothesis. Both The low oxygen content of the perfusate in isolated heart preparations leaves the possibility that the observed increases in ADP and AMP are a consequence of relative hypoxia and might not occur in bloodperfused organs. Balaban and colleagues'2,13 found no significant changes in high energy phosphate concentrations of intact dog hearts with 31P nuclear magnetic resonance (NMR) during either pacing or epinephrine infusion in the steady state.'2,'3 Transient changes are also absent during pacing. 13 Robitaille et al'4 obtained similar results with dobutamine or isoproterenol infusion. Whether these interventions increased cardiac adenosine release is unknown. The purpose of this study was to measure high energy phosphate concentrations via lip NMR in dog hearts during NE infusion, an intervention known to increase cardiac adenosine release. 15 Because adenosine release is phasic during catecholamine infusion,'667 we also measured the time course of adenosine release and high energy phosphate concentrations.
Materials and Methods
Male dogs (n=11) were anesthetized with intravenous sodium pentobarbital, 30 mg/kg initially with supplements as required. They were intubated and ventilated with oxygen with a Siemens respirator. A water-circulating heating pad was used to maintain body temperature. A femoral artery and vein were cannulated for measurement of arterial pressure, administration of fluids, and blood gas sampling. Arterial blood gases were measured periodically, and ventilation was adjusted or sodium bicarbonate was administered to maintain Pco2 at 35-45 mm Hg and pH between 7.35 and 7.45. Blood oxygen content was calculated using a model OSM3 hemoximeter (Radiometer America, Inc., Westlake, Ohio).
After a median sternotomy, the pericardial fat pad was exposed and removed. Platinum pacing electrodes were sewn to the right atrial appendage. Teflon catheters (Angio-Set, 22 
Experimental Protocol
After a hemodynamic steady state was achieved with the dog in the magnet, we collected three sequential baseline 31P NMR spectra over a 6-minute period. Arterial and coronary sinus blood samples were drawn at the midpoint of this period. Immediately after this control period, intracoronary NE infusion was begun at 12 ,ug/min (1.2 ml/min). NE was infused for 16 minutes while eight sequential 31P NMR spectra were collected. Blood samples for adenosine (seven dogs) and blood gas analyses (nine dogs) were drawn after 5 and 15 minutes of NE infusion. Blood samples were also collected at 10 minutes in seven dogs. After 16 minutes the NE infusion was stopped. Crystal violet dye was infused through the coronary catheter to verify infusion into both coronary arteries. The dog was euthanatized with intravenous KCl. The heart was excised and the weight of the left ventricle determined.
In one dog the quality of the 31P NMR spectra deteriorated significantly during NE infusion. 31P NMR data were rejected from this dog, but hemodynamic and adenosine data were included.
In four dogs, 31p NMR spectra were collected during 16 minutes of isotonic saline infusion as a control experiment. These dogs were identically instrumented including the coronary sinus shunt, but no adenosine or blood gas samples were collected. Two of these dogs received a subsequent NE infusion and were included in the results of that series.
Adenosine Measurements
For each adenosine sample, 5 ml blood was added to an iced test tube containing 360 ,ul collecting solution. The collecting solution contained 50 ,uM dipyridamole to stop adenosine uptake, 3 ,uM EHNA [erythro-9-(2-hydroxyl-3-nonyl) adenine] to inhibit adenosine deaminase, and 4 mM EDTA to inhibit adenosine formation via ecto-5'-nucleotidase, all in isotonic saline. After the solution was mixed gently, these tubes were immediately centrifuged and the supernatant removed. Samples with any visible hemolysis were rejected. Plasma proteins were precipitated by addition of 120 ,ul perchloric acid to 2 ml supernatant. After centrifugation at 1,360g, the acid supernatant was neutralized with K2CO3, filtered (0.22 gm), and frozen for later analysis.
Adenosine concentration was measured using a radioimmunoassay (Peninsula Laboratories). Adenosine release was calculated as the product of coronary sinus plasma flow and the venous-arterial adenosine concenpacing stimulator was driven at the lowest multiple of 30 tration difference. Figures 1 and 2 . Figure 1 suggests a slight decrease in the PCr peak height early during NE infusion, followed by a recovery. This is supported by the difference spectra in Figure 2 . Six of eight animals Changes in the PCr/ATP area ratio for all dogs are presented in Figure 3 . There was a transient fall in this ratio (9.2% at 7 minutes) early during NE infusion followed by a recovery to the baseline level.
Discussion
The principal result of this study is that there is a transient decrease in the PCr/ATP ratio in the intact dog heart during an intervention that greatly increased cardiac adenosine release. During continued NE infusion, however, the PCr/ATP ratio returned to control levels while adenosine release remained much higher than at rest.
The absence of a steady-state decline in high energy phosphates in canine myocardium during NE infusion agrees with similar observations during pacing or infusion of epinephrine, phenylephrine, dobutamine, or isoproterenol. ' In isolated rodent hearts the decline in PCr and ATP concentrations during catecholamine infusion is more pronounced and long lasting.9-1" These studies have suggested a mechanism of adenosine formation in which increased cytosolic AMP serves as the stimulus, either by itself or in combination with allosteric stimulation of cytosolic 5'-nucleotidase. The minimal changes in high energy phosphates in intact dog hearts during catecholamine infusion contrast with larger and more persistent changes in isolated rodent hearts.9-11 This may reflect inadequate oxygenation during catecholamine infusion in isolated hearts because of the low oxygen content of the perfusate. Alternatively, the metabolic substrate in the isolated hearts (glucose or glucose plus pyruvate) may be inadequate to maintain PCr concentrations during increased energy demand. It is also possible that this is a characteristic of rodent hearts, since a 3ip NMR study of in vivo rat hearts found steady-state decreases in the PCr/ATP ratio during NE infusion. 26 The PCr/ATP ratio is used to evaluate high energy phosphate concentration changes in 31P NMR experiments using surface coils. The use of a ratio circumvents artifactual changes in individual peak areas caused by time-dependent changes in the magnetic field, heart rate, or movement of the coil. When both PCr and ATP concentrations change, however, the PCr/ATP ratio can be misleading. In isolated guinea pig hearts during 20 minutes of NE infusion at constant flow, the PCr/ATP ratio falls initially but subsequently increases above resting values.9 In this case both PCr and ATP concentrations fell, indicating steady-state decreases in high energy phosphates that were not reflected in the PCr/ ATP ratio. However, the PCr/ATP ratio is an appropriate index of high energy phosphates when ATP concentration is essentially constant, as it is in blood-perfused preparations. '2-14,27 In previous studies adenosine release has been neg- PCr/Pi ratio closely parallels the phosphorylation potential.9,20 Unfortunately, the low total Pi content and poor resolution of this peak into intracellular and extracellular components make calculation of this ratio unreliable in our experiments.
Cardiac 3ip NMR spectra acquired with these techniques are weighted in favor of the subepicardium. Deussen et al17 have provided evidence that adenosine formation occurs primarily in the subendocardium in the dog heart during isoproterenol infusion. It is therefore possible that larger changes in the PCr/ATP ratio took place in subendocardial regions in our experiments. However, spatially localized 31P NMR spectra in dog hearts during dobutamine or isoproterenol infusion have failed to detect changes in the subendocardial PCr/ATP ratio.14 Increased cardiac adenosine release is often correlated with a decrease in the oxygen supply/consumption ratio (Do2/Vo2),6 which is reflected in the coronary sinus oxygen content since arterial oxygen content did not change. In these experiments we found increased adenosine release despite an increase in this ratio after 5 minutes of NE infusion and ratios at the control level thereafter. The increased Do2/Vo2 at 5 minutes probably resulted from increased Do2 via the increased arterial pressure. It is possible that Do2/Vo2 decreased before our first sampling at 5 minutes. Even so, adenosine release was declining between 5 and 15 minutes while coronary sinus oxygen content was falling. These results argue against an obligatory role for decreased Do2/Vo2 in cardiac adenosine formation. It is also possible that stimulation of myocyte a-receptors contributes to adenosine formation in this situation. 28 In summary, during intracoronary NE infusion in intact dog hearts, we found persistently increased adenosine release with a small transient change in the PCr/ATP ratio. Furthermore, adenosine release did not correlate with the oxygen supply/consumption ratio. We conclude that cardiac adenosine formation can increase under conditions for which there is no evidence of inadequate oxygenation and very little change in cytosolic high energy phosphate concentrations.
Appendix
The purpose of these calculations is to determine whether the transient decrease in the PCr/ATP ratio that we observed can account for the increase in cardiac adenosine release, given the assumption that adenosine is formed from AMP by a cytosolic 5-nucleotidase. The rate of intracellular adenosine formation is certain to be much greater than the rate of adenosine release into venous plasma because of uptake (or reuptake) and metabolism of adenosine by myocytes and endothelial cells. It is therefore impossible to estimate the absolute rate of intracellular adenosine formation from our data. Relative rates of adenosine formation should be predictable, however, based on known kinetics of the enzymes involved.
If we assume equilibrium of the creatine kinase reaction, gM and a,=64 ,uM yields v2/v,= 1.57. We can therefore expect a 57% increase in adenosine formation based on the PCr/ATP ratio decrease and the kinetics of this enzyme. If we eliminate the two dogs that had net adenosine uptake at rest, the resting adenosine release averaged 0.233 nmol * min-1 . 100 g'. After 5 minutes of NE the release rate was 12.3 nmol * min-m * 100 g ', a 53-fold increase. This is far more than can be accounted for based on the above calculations.
Other forms of 5'-nucleotidase would produce even smaller increases in adenosine formation because they are inhibited by ADP. The required increase in adenosine formation might be smaller than 53-fold if one or more of the adenosine uptake or metabolic pathways becomes saturated. The Km values for the highest affinity adenosine transporters are in the micromolar range.31,32 Our highest plasma concentrations are about 0.2 MM, which may correspond to an interstitial concentration of about 1 MIM.33 It therefore seems unlikely that adenosine uptake is saturated under these conditions.
